rs117749531
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2
The NM_004281.4(BAG3):c.1240G>A(p.Glu414Lys) variant causes a missense change. The variant allele was found at a frequency of 0.000222 in 1,614,130 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_004281.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -13 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000243 AC: 37AN: 152148Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000354 AC: 89AN: 251308Hom.: 0 AF XY: 0.000331 AC XY: 45AN XY: 135846
GnomAD4 exome AF: 0.000220 AC: 321AN: 1461864Hom.: 1 Cov.: 76 AF XY: 0.000230 AC XY: 167AN XY: 727234
GnomAD4 genome AF: 0.000243 AC: 37AN: 152266Hom.: 0 Cov.: 31 AF XY: 0.000215 AC XY: 16AN XY: 74452
ClinVar
Submissions by phenotype
not provided Benign:5
- -
- -
- -
This variant is associated with the following publications: (PMID: 25617006) -
BAG3: BP4, BS1, BS2 -
not specified Uncertain:1Benign:1
Variant classified as Uncertain Significance - Favor Benign. The Glu414Lys varia nt in BAG3 has not been previously reported in individuals with cardiomyopathy, but has been identified in 3/8600 European American chromosomes by the NHLBI Exo me Sequencing Project (http://evs.gs.washington.edu/EVS/; dbSNP rs117749531). Gl utamic acid (Glu) at position 414 is not conserved in mammals or evolutionarily distant species, raising the possibility that a change at this position may be t olerated. Additional computational prediction tools suggest that this variant ma y not impact the protein, though this information is not predictive enough to ru le out pathogenicity. In summary, while the clinical significance of the Glu414L ys variant is uncertain, these data suggest that it is more likely to be benign. -
Variant summary: BAG3 c.1240G>A (p.Glu414Lys) results in a conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.00033 in 282702 control chromosomes, including 1 homozygote. The observed variant frequency is approximately 8-fold of the estimated maximal expected allele frequency for a pathogenic variant in BAG3 causing Dilated Cardiomyopathy phenotype (3.9e-05). A variant, reported as BAG3 G414K (correctly name should be E414K), was listed to be found in a cohort of patients affected with sporadic inclusion body myositis (Weihl_2015), however no supportive evidence for causality was provided. To our knowledge, no experimental evidence demonstrating its impact on protein function have been reported. ClinVar contains an entry for this variant (Variation ID: 162784). Based on the evidence outlined above, the variant was classified as benign. -
Dilated cardiomyopathy 1HH Uncertain:1
This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -
Myofibrillar myopathy 6 Benign:1
This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Myofibrillar myopathy 6;C3151293:Dilated cardiomyopathy 1HH Benign:1
- -
Long QT syndrome Benign:1
Criteria: BS1, BP1 -
Cardiovascular phenotype Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at